Taclonex Ointment Generic Name & Formulations
Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.
Vit. D3 derivative + topical steroid.
Oint—60g, 100g; Susp—60g, 2x60g
Taclonex Ointment Indications
Taclonex Ointment Dosage and Administration
Adults and Children
<12yrs: not established. Apply to affected areas once daily for up to 4 weeks; discontinue when control is achieved. 12–17yrs: max 60g/wk. ≥18yrs: max 100g/wk. Limit treatment area to max 30% body surface area. Do not occlude.
Taclonex Ointment Contraindications
Taclonex Ointment Boxed Warnings
Taclonex Ointment Warnings/Precautions
Avoid use near eyes, on face, groin, or axillae, or if atrophy is present at treatment site. Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Avoid sun, UV light (eg, phototherapy). Allergic contact dermatitis. Pregnancy. Nursing mothers.
Taclonex Ointment Pharmacokinetics
Taclonex Ointment Interactions
Systemic absorption potentiated by other corticosteroids.
Taclonex Ointment Adverse Reactions
Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.
Taclonex Ointment Clinical Trials
Taclonex Ointment Note
Taclonex Ointment Patient Counseling